• Login
    View Item 
    •   Home
    • HSE
    • Health Protection Surveillance Centre (HPSC)
    • View Item
    •   Home
    • HSE
    • Health Protection Surveillance Centre (HPSC)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Map of Submissions

    Home Page
    UlsterN
    5079
    UlsterS
    5079
    Connacht
    1698
    Munster
    58
    Leinster
    465

    Browse

    All of Lenus, The Irish Health RepositoryCommunitiesTitleAuthorsDate publishedSubjectsThis CollectionTitleAuthorsDate publishedSubjects

    My Account

    LoginRegister

    About

    About LenusDirectory of Open Access JournalsOpen Access Publishing GuideNational Health Library & Knowledge ServiceGuide to Publishers' PoliciesFAQsTerms and ConditionsVision StatementORCID Unique identifiers for ResearchersHSE position statement on Open AccessNational Open Research Forum (NORF)Zenodo (European Open Research repository)

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Towards tuberculosis elimination: an action framework for low-incidence countries.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    TBElimination.pdf
    Size:
    1.378Mb
    Format:
    PDF
    Download
    Authors
    Lönnroth, Knut
    Migliori, Giovanni Battista
    Abubakar, Ibrahim
    D'Ambrosio, Lia
    de Vries, Gerard
    Diel, Roland
    Douglas, Paul
    Falzon, Dennis
    Gaudreau, Marc-Andre
    Goletti, Delia
    González Ochoa, Edilberto R
    LoBue, Philip
    Matteelli, Alberto
    Njoo, Howard
    Solovic, Ivan
    Story, Alistair
    Tayeb, Tamara
    van der Werf, Marieke J
    Weil, Diana
    Zellweger, Jean-Pierre
    Abdel Aziz, Mohamed
    Al Lawati, Mohamed R M
    Aliberti, Stefano
    Arrazola de Oñate, Wouter
    Barreira, Draurio
    Bhatia, Vineet
    Blasi, Francesco
    Bloom, Amy
    Bruchfeld, Judith
    Castelli, Francesco
    Centis, Rosella
    Chemtob, Daniel
    Cirillo, Daniela M
    Colorado, Alberto
    Dadu, Andrei
    Dahle, Ulf R
    De Paoli, Laura
    Dias, Hannah M
    Duarte, Raquel
    Fattorini, Lanfranco
    Gaga, Mina
    Getahun, Haileyesus
    Glaziou, Philippe
    Goguadze, Lasha
    Del Granado, Mirtha
    Haas, Walter
    Järvinen, Asko
    Kwon, Geun-Yong
    Mosca, Davide
    Nahid, Payam
    Nishikiori, Nobuyuki
    Noguer, Isabel
    O'Donnell, Joan
    Pace-Asciak, Analita
    Pompa, Maria G
    Popescu, Gilda G
    Robalo Cordeiro, Carlos
    Rønning, Karin
    Ruhwald, Morten
    Sculier, Jean-Paul
    Simunović, Aleksandar
    Smith-Palmer, Alison
    Sotgiu, Giovanni
    Sulis, Giorgia
    Torres-Duque, Carlos A
    Umeki, Kazunori
    Uplekar, Mukund
    van Weezenbeek, Catharina
    Vasankari, Tuula
    Vitillo, Robert J
    Voniatis, Constantia
    Wanlin, Maryse
    Raviglione, Mario C
    Show allShow less
    Affiliation
    1Global TB Programme, World Health Organization, Geneva, Switzerland Both authors contributed equally. 2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy Both authors contributed equally. 3TB Section, University College London and Public Health England, London, UK. 4WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy. 5KNCV Tuberculosis Foundation, The Hague, The Netherlands. 6University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, Germany. 7Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, Australia. 8Global TB Programme, World Health Organization, Geneva, Switzerland. 9Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, Canada. 10National Institute for Infectious Diseases, Rome, Italy. 11Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine "Pedro Kourí", Havana, Cuba. 12Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA. 13TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, Slovakia. 14Find and Treat, London, UK. 15National TB Control Programme, Ministry of Health, Riyadh, Saudi Arabia. 16European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. 17Swiss Lung Association, Bern, Switzerland. 18WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt. 19Ministry of Health, Muscat, Oman. 20Università degli Studi di Milano - Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, Italy. 21Belgian Lung and Tuberculosis Association, Brussels, Belgium. 22Ministry of Health, Brasilia, Brazil. 23Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, Italy. 24US Agency for International Development, Washington, DC, USA. 25Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden. 26University of Brescia, Brescia, Italy. 27Ministry of Health, Jerusalem, Israel. 28IRCCS San Raffaele Scientific Institute, Milan, Italy. 29Advocates for Health International, San Diego, CA, USA. 30TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, Denmark. 31Norwegian Institute of Public Health, Oslo, Norway. 32Médecins sans Frontières, Rome, Italy. 33General Directorate of Health, Lisbon, Portugal. 34Istituto Superiore di Sanita, Rome, Italy. 35National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, Greece. 36International Federation of Red Cross and Red Crescent Societies, Geneva, Switzerland. 37WHO Regional Office for the Americas, Washington, DC, USA. 38Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. 39Finnish Lung Health Association, Helsinki, Finland Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, Finland. 40Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of Korea. 41International Organization for Migration, Geneva, Switzerland. 42University of California, San Francisco, CA, USA American Thoracic Society (ATS), New York, NY, USA. 43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, Philippines. 44Instituto de Salud Carlos III, Madrid, Spain. 45HSE Health Protection Surveillance Centre, Dublin, Ireland. 46Ministry for Health, Valletta, Malta. 47Ministry of Health, Rome, Italy. 48Pneumology Institute Marius Nasta, Bucharest, Romania. 49Coimbra University Hospital, Coimbra, Portugal. 50Statens Serum Institut (SSI), Copenhagen, Denmark. 51Institut Jules Bordet (ULB), Brussels, Belgium. 52Croatian National Institute of Public Health, Zagreb, Croatia. 53Health Protection Scotland, Glasgow, UK. 54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy. 55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, Colombia. 56Ministry of Health, Labour and Welfare, Tokyo, Japan. 57Finnish Lung Health Association, Helsinki, Finland. 58Caritas Internationalis, Geneva, Switzerland. 59Ministry of Health, Nicosia, Cyprus. 60Fonds des Affections Respiratoires (FARES), Brussels, Belgium.
    Issue Date
    2015-04
    Keywords
    TUBERCULOSIS
    INFECTIOUS DISEASE
    EPIDEMIOLOGY
    
    Metadata
    Show full item record
    Citation
    Towards tuberculosis elimination: an action framework for low-incidence countries. 2015, 45 (4):928-52 Eur. Respir. J.
    Publisher
    ERS Journals
    Journal
    The European respiratory journal
    URI
    http://hdl.handle.net/10147/558998
    DOI
    10.1183/09031936.00214014
    PubMed ID
    25792630
    Additional Links
    http://erj.ersjournals.com/content/45/4/928.long
    Abstract
    This paper describes an action framework for countries with low tuberculosis (TB) incidence (<100 TB cases per million population) that are striving for TB elimination. The framework sets out priority interventions required for these countries to progress first towards "pre-elimination" (<10 cases per million) and eventually the elimination of TB as a public health problem (less than one case per million). TB epidemiology in most low-incidence countries is characterised by a low rate of transmission in the general population, occasional outbreaks, a majority of TB cases generated from progression of latent TB infection (LTBI) rather than local transmission, concentration to certain vulnerable and hard-to-reach risk groups, and challenges posed by cross-border migration. Common health system challenges are that political commitment, funding, clinical expertise and general awareness of TB diminishes as TB incidence falls. The framework presents a tailored response to these challenges, grouped into eight priority action areas: 1) ensure political commitment, funding and stewardship for planning and essential services; 2) address the most vulnerable and hard-to-reach groups; 3) address special needs of migrants and cross-border issues; 4) undertake screening for active TB and LTBI in TB contacts and selected high-risk groups, and provide appropriate treatment; 5) optimise the prevention and care of drug-resistant TB; 6) ensure continued surveillance, programme monitoring and evaluation and case-based data management; 7) invest in research and new tools; and 8) support global TB prevention, care and control. The overall approach needs to be multisectorial, focusing on equitable access to high-quality diagnosis and care, and on addressing the social determinants of TB. Because of increasing globalisation and population mobility, the response needs to have both national and global dimensions.
    Item Type
    Article
    Language
    en
    ISSN
    1399-3003
    ae974a485f413a2113503eed53cd6c53
    10.1183/09031936.00214014
    Scopus Count
    Collections
    Health Protection Surveillance Centre (HPSC)

    entitlement

    Related articles

    • Towards elimination of tuberculosis in New Zealand.
    • Authors: Verrall AJ, Hill PC, Thorburn D, Maze M, Perumal L, Grimwade K, Thornley CN, Freeman J, Nisbet M, Blackmore TK
    • Issue date: 2020 Apr 24
    • Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    • Authors: Fears R, Kaufmann S, Ter Meulen V, Zumla A, EASAC Working Group
    • Issue date: 2010 May
    • [Reform of Japan's NTP and its technical perspectives].
    • Authors: Mori T
    • Issue date: 2004 Oct
    • Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    • Authors: Pablos-Mendez A, Gowda DK, Frieden TR
    • Issue date: 2002
    • Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.
    • Authors: Ahmad S, Mokaddas E, Al-Mutairi NM
    • Issue date: 2018 Sep
    Health Library Ireland | Health Service Executive | Jervis House, Jervis Street | Republic of Ireland | Eircode: D01 W596
    lenus@hse.ie | Tel: +353-1-7786275
    DSpace software copyright © 2002-2017  DuraSpace
    Contact Us | Disclaimer
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.